Skip to main content
. 2022 Jul;11(7):1279–1291. doi: 10.21037/tlcr-22-148

Table 1. Demographics of the study population.

Variable Number of patients (%)
Age (year), median (25th of 75th percentile) 67 (60 to 72)*
Sex
   Female 335 (35.3)
   Male 614 (64.7)
Smoking
   Never smoker 429 (45.2)
   Current or former smoker 520 (54.8)
History of malignancy other than lung cancer
   Absent 815 (85.9)
   Present 134 (14.1)
Stage
   IA 467 (49.2)
   IB 231 (24.3)
   IIA 65 (6.9)
   IIB 186 (19.6)
Location
   Non-lower lobe 535 (56.4)
   Lower lobe 414 (43.6)
Histology
   Squamous cell carcinoma 311 (32.8)
   Adenocarcinoma 638 (67.2)
Adjuvant treatment
   Performed 259 (27.3)
   No 690 (72.7)
Surgery method
   Lobectomy 890 (93.8)
   Bilobectomy or pneumonectomy 59 (6.2)
Recurrence
   No 755 (79.6)
   Locoregional recurrence 69 (7.3)
   Distant metastasis 125 (13.1)
Death
   Alive 705 (74.3)
   Death (lung cancer) 186 (19.6)
   Death (with a cause other than lung cancer)** 58 (6.1)

*, median (25th to 75th percentile); **, patients were classified as censored at the time of death.